Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Reviews in Urology
|
August 10, 2011
Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada
J Curtis Nickel, Dean Tripp, Allan Gordon, et al.
Journal of the American College of Cardiology
|
January 25, 2011
Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial
Stephen J Nicholls, Allan Gordon, Jan Johansson, et al.
Cardiovascular Research
|
November 9, 2025
The ghrelin receptor agonist AC01 improves cardiomyocyte contractility through Gαi signalling and without Ca2+ mobilization
Lars H Lund, Camilla Hage, Mattias Carlström, et al.
Pain Research & Management
|
June 26, 2010
Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain
Allan Gordon, Saifudin Rashiq, Dwight E Moulin, et al.
Pain
|
July 28, 2004
An integrated undergraduate pain curriculum, based on IASP curricula, for six health science faculties
Judy Watt-Watson, Judi Hunter, Peter Pennefather, et al.
The Clinical Journal of Pain
|
January 19, 2013
Understanding the information and service needs of young adults with chronic pain: perspectives of young adults and their providers
Jennifer Stinson, Meghan White, Lisa Isaac, et al.
The Journal of Pain
|
June 17, 2015
Long-Term Outcome of the Management of Chronic Neuropathic Pain: A Prospective Observational Study
Dwight E Moulin, A John Clark, Allan Gordon, et al.
The Clinical Journal of Pain
|
May 9, 2017
Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes
Elizabeth G VanDenKerkhof, Larry Stitt, Alexander J Clark, et al.
Atherosclerosis
|
February 13, 2016
RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease
Dean Gilham, Sylwia Wasiak, Laura M Tsujikawa, et al.
Cardiovascular Drugs and Therapy
|
February 22, 2012
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies
Stephen J Nicholls, Allan Gordon, Jan Johannson, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Reviews in Urology
|
August 10, 2011
Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada
J Curtis Nickel, Dean Tripp, Allan Gordon, et al.
Journal of the American College of Cardiology
|
January 25, 2011
Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial
Stephen J Nicholls, Allan Gordon, Jan Johansson, et al.
Cardiovascular Research
|
November 9, 2025
The ghrelin receptor agonist AC01 improves cardiomyocyte contractility through Gαi signalling and without Ca2+ mobilization
Lars H Lund, Camilla Hage, Mattias Carlström, et al.
Pain Research & Management
|
June 26, 2010
Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain
Allan Gordon, Saifudin Rashiq, Dwight E Moulin, et al.
Pain
|
July 28, 2004
An integrated undergraduate pain curriculum, based on IASP curricula, for six health science faculties
Judy Watt-Watson, Judi Hunter, Peter Pennefather, et al.
The Clinical Journal of Pain
|
January 19, 2013
Understanding the information and service needs of young adults with chronic pain: perspectives of young adults and their providers
Jennifer Stinson, Meghan White, Lisa Isaac, et al.
The Journal of Pain
|
June 17, 2015
Long-Term Outcome of the Management of Chronic Neuropathic Pain: A Prospective Observational Study
Dwight E Moulin, A John Clark, Allan Gordon, et al.
The Clinical Journal of Pain
|
May 9, 2017
Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes
Elizabeth G VanDenKerkhof, Larry Stitt, Alexander J Clark, et al.
Atherosclerosis
|
February 13, 2016
RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease
Dean Gilham, Sylwia Wasiak, Laura M Tsujikawa, et al.
Cardiovascular Drugs and Therapy
|
February 22, 2012
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies
Stephen J Nicholls, Allan Gordon, Jan Johannson, et al.
Page
of 6